Tirz is a novel medication that mimics the actions of two natural hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). It is primarily used to improve blood sugar control in adults with type 2 diabetes. Additionally, it has shown potential for significant weight loss in clinical trials, making it a promising option for managing obesity and related metabolic conditions. Tirz works by enhancing insulin secretion, reducing appetite, and promoting a feeling of fullness.





